Legend Biotech (LEGN) Short Interest Ratio & Short Volume $35.58 -0.52 (-1.44%) As of 10:12 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Legend Biotech Short Interest DataLegend Biotech (LEGN) has a short interest of 20.90 million shares. This marks a -8.93% decrease in short interest from the previous month. The short interest ratio (days to cover) is 13.8, indicating that it would take 13.8 days of the average trading volume of 1.35 million shares to cover all short positions.Current Short Interest20,900,000 sharesPrevious Short Interest22,950,000 sharesChange Vs. Previous Month-8.93%Dollar Volume Sold Short$658.98 millionShort Interest Ratio13.8 Days to CoverLast Record DateJanuary 15, 2025Outstanding Shares182,630,000 sharesPercentage of Shares Shorted11.44%Today's Trading Volume29,972 sharesAverage Trading Volume1,348,934 sharesToday's Volume Vs. Average2% Short Selling Legend Biotech? Sign up to receive the latest short interest report for Legend Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLEGN Short Interest Over TimeLEGN Days to Cover Over TimeLEGN Percentage of Float Shorted Over Time Legend Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/202520,900,000 shares $658.98 million -8.9%N/A13.8 $31.53 12/31/202420,900,000 shares $680.09 million -8.9%N/A13.8 $32.54 12/15/202422,950,000 shares $806.00 million -3.6%N/A15.5 $35.12 11/30/202423,810,000 shares $1.00 billion +3.9%N/A17.5 $42.07 11/15/202422,910,000 shares $874.93 million +44.5%N/A17.5 $38.19 10/31/202415,860,000 shares $714.02 million +32.7%N/A14.3 $45.02 10/15/202411,950,000 shares $536.67 million -1.0%N/A12.2 $44.91 9/30/202412,070,000 shares $588.17 million +15.3%N/A12.7 $48.73 9/15/202410,470,000 shares $526.75 million +2.5%N/A11.3 $50.31 8/31/202410,220,000 shares $588.16 million -4.6%N/A10.8 $57.55 Get the Latest News and Ratings for LEGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Legend Biotech and its competitors with MarketBeat's FREE daily newsletter. 8/15/202410,710,000 shares $597.08 million +6.3%N/A9.6 $55.75 7/31/202410,080,000 shares $568.41 million -8.9%N/A8.5 $56.39 7/15/202411,060,000 shares $597.13 million -0.9%N/A9.1 $53.99 6/30/202411,160,000 shares $494.28 million +1.5%N/A9.9 $44.29 6/15/202411,000,000 shares $466.95 million -17.0%N/A9.7 $42.45 5/31/202413,260,000 shares $530.53 million +2.2%N/A11 $40.01 5/15/202412,980,000 shares $593.96 million -2.3%N/A12.2 $45.76 4/30/202413,280,000 shares $580.87 million +21.0%N/A13.5 $43.74 4/15/202410,980,000 shares $567.78 million +9.9%N/A10.9 $51.71 3/31/20249,990,000 shares $560.34 million -5.0%N/A10.2 $56.09 3/15/202410,510,000 shares $672.85 million +2.4%N/A10.8 $64.02 2/29/202410,260,000 shares $668.54 million +3.2%N/A11.1 $65.16 2/15/20249,940,000 shares $567.08 million -1.1%N/A9.7 $57.05 1/31/202410,050,000 shares $553.35 million +0.4%N/A9.8 $55.06 1/15/202410,010,000 shares $608.31 million +0.7%N/A10.4 $60.77 12/31/20239,940,000 shares $598.09 million -7.4%N/A11.5 $60.17 12/15/202310,730,000 shares $657.64 million -0.2%N/A13 $61.29 11/30/202310,750,000 shares $653.82 million +21.1%N/A14.2 $60.82 11/15/20238,880,000 shares $576.93 million +9.2%N/A15.7 $64.97 10/31/20238,130,000 shares $537.15 million -0.4%N/A16.1 $66.07 10/15/20238,160,000 shares $542.64 million +4.8%N/A16.1 $66.50 9/30/20237,790,000 shares $523.25 million +8.0%N/A14.7 $67.17 9/15/20237,210,000 shares $478.38 million -2.8%N/A13.4 $66.35 8/31/20237,420,000 shares $514.65 million +7.2%N/A12.1 $69.36 8/15/20236,920,000 shares $463.29 million +1.6%N/A10 $66.95 7/31/20236,810,000 shares $514.29 million +15.8%N/A9.8 $75.52 7/15/20235,880,000 shares $408.42 million -1.5%N/A7.8 $69.46 6/30/20235,970,000 shares $412.11 million +5.9%N/A6.6 $69.03 6/15/20235,640,000 shares $401.85 million +24.5%N/A6.2 $71.25 5/31/20234,530,000 shares $290.69 million -3.2%N/A5.4 $64.17The Shadow President? (Ad)President Trump has already launched a "shock and awe" flurry of new Executive Orders... He's withdrawn from the World Health Organization... exited the Paris climate accord... and begun dismantling many Federal programs... But there's ONE executive order that could go down in history as the most important of all.It's likely just the start of a MUCH more radical move. 5/15/20234,680,000 shares $342.30 million +13.6%N/A5.8 $73.14 4/30/20234,120,000 shares $283.09 million -21.4%N/A5.2 $68.71 4/15/20235,240,000 shares $277.82 million -11.2%N/A6.4 $53.02 3/31/20235,900,000 shares $284.50 million +15.5%N/A9.3 $48.22 3/15/20235,110,000 shares $239.71 million +14.8%N/A8.3 $46.91 2/28/20234,450,000 shares $205.50 million +12.7%N/A6.7 $46.18 2/15/20233,950,000 shares $192.96 million +7.1%N/A6 $48.85 1/31/20233,690,000 shares $186.35 million +0.8%N/A5.5 $50.50 1/15/20233,660,000 shares $209.97 million +1.7%N/A5.4 $57.37 12/30/20223,600,000 shares $179.71 million -19.1%N/A5.2 $49.92 12/15/20224,450,000 shares $230.69 million +13.2%N/A6.4 $51.84 11/30/20223,930,000 shares $202.43 million +6.5%N/A5.4 $51.51 11/15/20223,690,000 shares $193.73 million -38.7%N/A5.2 $52.50 10/31/20226,020,000 shares $299.92 million -13.0%N/A8.6 $49.82 10/15/20226,920,000 shares $275.07 million +2.5%N/A8.7 $39.75 9/30/20226,750,000 shares $275.40 million +22.3%N/A8.8 $40.80 9/15/20225,520,000 shares $240.12 million +22.7%N/A7.3 $43.50 8/31/20224,500,000 shares $209.21 million +10.8%N/A6.1 $46.49 8/15/20224,060,000 shares $189.68 million +17.0%N/A5.6 $46.72 7/31/20223,470,000 shares $163.92 million -18.7%N/A4.8 $47.24 7/15/20224,270,000 shares $228.23 million -8.4%N/A6.7 $53.45 6/30/20224,660,000 shares $256.30 million -3.9%N/A7.6 $55.00 6/15/20224,850,000 shares $211.27 million -2.8%N/A7.9 $43.56 5/31/20224,990,000 shares $211.03 million +9.2%N/A7.1 $42.29 5/15/20224,570,000 shares $179.88 million +16.0%N/A5.8 $39.36 4/30/20223,940,000 shares $158.19 million -9.8%N/A4.9 $40.15 4/15/20224,370,000 shares $177.60 million +7.4%N/A5.5 $40.64 3/31/20224,070,000 shares $147.90 million -11.3%N/A5.3 $36.34 3/15/20224,590,000 shares $163.54 million -5.4%N/A5.7 $35.63 2/28/20224,850,000 shares $192.01 million +4.3%N/A6.1 $39.59 2/15/20224,650,000 shares $188.79 million No ChangeN/A6.1 $40.60 1/31/20224,650,000 shares $198.28 million -16.4%N/A6.4 $42.64 1/15/20225,560,000 shares $230.74 million -6.6%N/A7.7 $41.50 12/31/20215,950,000 shares $277.33 million +60.4%N/A8.5 $46.61 12/15/20213,710,000 shares $152.63 million +23.3%N/A5.3 $41.14 11/30/20213,010,000 shares $155.05 million -3.2%N/A5.5 $51.51 11/15/20213,110,000 shares $152.73 million +44.7%N/A7.1 $49.11 10/29/20212,150,000 shares $112.88 million +16.9%N/A5 $52.50 10/15/20211,840,000 shares $95.51 million +21.1%N/A4.5 $51.91 9/30/20211,520,000 shares $76.85 million +16.0%N/A3.7 $50.56 9/15/20211,310,000 shares $53.15 million No ChangeN/A3.5 $40.57 8/31/20211,310,000 shares $50.16 million -10.3%N/A3.5 $38.29 8/13/20211,460,000 shares $59.36 million -31.5%1.1%3.5 $40.66 7/30/20212,130,000 shares $91.65 million -2.3%1.7%4.1 $43.03 7/15/20212,180,000 shares $85.85 million +15.3%1.7%4.3 $39.38 6/30/20211,890,000 shares $77.58 million -6.9%1.5%4 $41.05 6/15/20212,030,000 shares $78.85 million -11.0%1.6%4.2 $38.84 5/28/20212,280,000 shares $89.76 million +34.9%1.8%5 $39.37 5/14/20211,690,000 shares $52.42 million -8.7%1.3%3.8 $31.02 4/30/20211,850,000 shares $55.70 million -22.3%1.4%5.6 $30.11The Shadow President? (Ad)President Trump has already launched a "shock and awe" flurry of new Executive Orders... He's withdrawn from the World Health Organization... exited the Paris climate accord... and begun dismantling many Federal programs... But there's ONE executive order that could go down in history as the most important of all.It's likely just the start of a MUCH more radical move. 4/15/20212,380,000 shares $63.69 million +5.8%1.9%6.5 $26.76 3/31/20212,250,000 shares $64.69 million -40.8%1.8%5.8 $28.75 3/15/20213,800,000 shares $96.25 million +17.7%3.0%10.2 $25.33 2/26/20213,230,000 shares $88.76 million +12.9%2.5%8.6 $27.48 2/12/20212,860,000 shares $72.79 million +40.2%2.3%8.1 $25.45 1/29/20212,040,000 shares $52.53 million +6.8%1.6%6.2 $25.75 1/15/20211,910,000 shares $56.35 million No Change1.5%6.3 $29.50 LEGN Short Interest - Frequently Asked Questions What is Legend Biotech's current short interest? Short interest is the volume of Legend Biotech shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 20,900,000 shares of LEGN short. Learn More on Legend Biotech's current short interest. What is a good short interest ratio for Legend Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LEGN shares currently have a short interest ratio of 14.0. Learn More on Legend Biotech's short interest ratio. Which institutional investors are shorting Legend Biotech? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Legend Biotech: JPMorgan Chase & Co., Jane Street Group LLC, and Walleye Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Legend Biotech's short interest increasing or decreasing? Legend Biotech saw a drop in short interest in January. As of January 15th, there was short interest totaling 20,900,000 shares, a drop of 8.9% from the previous total of 22,950,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Legend Biotech's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Legend Biotech: Teva Pharmaceutical Industries Limited (2.39%), BeiGene, Ltd. (1.41%), Summit Therapeutics Inc. (2.70%), Moderna, Inc. (11.03%), Genmab A/S (0.22%), Viatris Inc. (2.96%), Intra-Cellular Therapies, Inc. (1.87%), Catalent, Inc. (8.12%), Dr. Reddy's Laboratories Limited (1.57%), Vaxcyte, Inc. (11.49%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($6.03 billion), Charter Communications, Inc. ($3.83 billion), Reddit, Inc. ($3.11 billion), The Kroger Co. ($2.85 billion), International Paper ($2.73 billion), Rivian Automotive, Inc. ($2.02 billion), SoFi Technologies, Inc. ($2.00 billion), Onsemi ($1.59 billion), Live Nation Entertainment, Inc. ($1.58 billion), and First Solar, Inc. ($1.53 billion). View all of the most shorted stocks. What does it mean to sell short Legend Biotech stock? Short selling LEGN is an investing strategy that aims to generate trading profit from Legend Biotech as its price is falling. LEGN shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Legend Biotech? A short squeeze for Legend Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LEGN, which in turn drives the price of the stock up even further. How often is Legend Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LEGN, twice per month. The most recent reporting period available is January, 15 2025. More Short Interest Resources from MarketBeat Related Companies TEVA Short Squeeze BGNE Short Squeeze SMMT Short Squeeze MRNA Short Squeeze GMAB Short Squeeze VTRS Short Squeeze ITCI Short Squeeze CTLT Short Squeeze RDY Short Squeeze PCVX Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LEGN) was last updated on 1/30/2025 by MarketBeat.com Staff From Our Partners#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredDonald Trump is about to free crypto from its chains …On October 25th, Juan said Bitcoin would cross $100,000 before the inauguration. Now he thinks it could rea...Weiss Ratings | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrillion-Dollar Crypto PlayPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Legend Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.